Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says
NCI, Dialogue Plan A National Tissue Bank
Group Chairmen Criticize NCI Budget Priorities
Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials
Kimes, Lenfant, To Retire
Cancer.gov Knocked Offline By Theft Of Routers
Six Centers Win Grants
PHS Plans Revitalization of Commissioned Corps
Funding Opportunities Listed (12-page issue).
Trending Stories
- An opportunity for Trump: Position U.S. cancer science to lead the world
- Former Maryland Governor Larry Hogan to receive Public Service Leadership Award from National Coalition for Cancer Survivorship
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs
To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reduced
NCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”
